Skip to main content

quetiapine

Generic: QUETIAPINE FUMARATE·Brand: QUETIAPINE FUMARATE, SEROQUEL, SEROQUEL XR, Seroquel

quetiapine: 4 clinical trials tracked.

quetiapine evidence translation

What we can confirm

4 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about quetiapine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors
Clinical Trial Registry Records (4)

Efficacy and Safety of Acute Followed by Maintenance rTMS in Treatment Resistant Depression: A Randomized Controlled Trial

NCT07760168Registry updated 2026-08-12·Phase 3
Not yet recruiting

Primary endpoint: To compare the efficacy of maintenance accelerated intermittent theta burst stimulation vs Quetiapine on symptomatology in terms of change in MADRS score in patients with treatment resistance depression

InterventionalRandomizedopen68 targetStarted 2026-08Completion 2028-08All India Institute of Medical Sciences, Bhubaneswar

CSP #2015 - Multicenter, Randomized, Double-blind Comparator Study of Antipsychotics Pimavanserin and Quetiapine for Parkinson''s Disease Psychosis (C-SAPP)

NCT04373317Registry updated 2026-08-19·Phase 4
Recruiting

Primary endpoint: CGI-I Psychosis

InterventionalRandomizedtriple358 targetStarted 2022-10Completion 2028-0824 sites · United StatesVA Office of Research and Development

A Pilot Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

NCT04164758Registry updated 2021-10-14·Phase 2·ACAD
Terminated

Primary endpoint: Treatment-emergent Adverse Events (TEAEs)

InterventionalRandomizedquadruple11 targetStarted 2019-10Completion 2020-0916 sites · United StatesACADIA Pharmaceuticals Inc.

A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics

NCT02431702Registry updated 2025-04-29·Phase 3
Completed

Primary endpoint: Part-2 (Disease Progression): Time to First Treatment Failure

InterventionalRandomizedopen337 enrolledStarted 2015-07Completion 2019-1138 sites · Brazil, Mexico, United StatesJanssen Scientific Affairs, LLC